These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28201965)

  • 1. Preparation and Characterization of Silymarin Synchronized and Sustained Release Dropping Pill.
    Liu ZH; Li XJ; Huang AW; Zhang J; Song HT
    Curr Drug Deliv; 2017; 14(5):650-657. PubMed ID: 28201965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs.
    Yan-yu X; Yun-mei S; Zhi-peng C; Qi-neng P
    Int J Pharm; 2006 Aug; 319(1-2):162-8. PubMed ID: 16687221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral bioavailability of silymarin formulated as a novel 3-day delivery system based on porous silica nanoparticles.
    Cao X; Fu M; Wang L; Liu H; Deng W; Qu R; Su W; Wei Y; Xu X; Yu J
    Acta Biomater; 2012 Jul; 8(6):2104-12. PubMed ID: 22343518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of silymarin synchronized-release microporous osmotic pump tablets.
    Zeng QP; Liu ZH; Huang AW; Zhang J; Song HT
    Drug Des Devel Ther; 2016; 10():519-31. PubMed ID: 26889080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synchronized and controlled release of multiple components in silymarin achieved by the osmotic release strategy.
    Xie Y; Lu Y; Qi J; Li X; Zhang X; Han J; Jin S; Yuan H; Wu W
    Int J Pharm; 2013 Jan; 441(1-2):111-20. PubMed ID: 23253304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on dissolution rate in vitro of silymarin dropping pill].
    Sun X; Qiu MF; Li SS; Wang JX; Shen Q; Jia W
    Zhongguo Zhong Yao Za Zhi; 2005 Feb; 30(4):263-5. PubMed ID: 15724400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of vitexin-rhamnoside in Beagle dog plasma and preliminary pharmacokinetics of Yixintong sustained release tablets].
    Qu L; Zheng HS; Feng NP; Li SM
    Zhongguo Zhong Yao Za Zhi; 2008 May; 33(10):1168-70. PubMed ID: 18720869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronized and sustained release of multiple components in silymarin from erodible glyceryl monostearate matrix system.
    Lu C; Lu Y; Chen J; Zhang W; Wu W
    Eur J Pharm Biopharm; 2007 May; 66(2):210-9. PubMed ID: 17196805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silymarin glyceryl monooleate/poloxamer 407 liquid crystalline matrices: physical characterization and enhanced oral bioavailability.
    Lian R; Lu Y; Qi J; Tan Y; Niu M; Guan P; Hu F; Wu W
    AAPS PharmSciTech; 2011 Dec; 12(4):1234-40. PubMed ID: 21948306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation of Shuxiong pulsatile controlled-release dropping pill].
    Chen H; Chen YZ; Xie QC; Lin SY; Lin JC; Jianc WN
    Zhong Yao Cai; 2013 Jul; 36(7):1155-8. PubMed ID: 24417154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on preparation and dissolution test in vitro of sustained-release dropping pills of curcumin].
    Fang Y; Xiang B; Pan ZH; Cao DY
    Zhong Yao Cai; 2010 Jan; 33(1):111-4. PubMed ID: 20518316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A silica-supported solid dispersion of bifendate using supercritical carbon dioxide method with enhanced dissolution rate and oral bioavailability.
    Cai C; Liu M; Li Y; Guo B; Chang H; Zhang X; Yang X; Zhang T
    Drug Dev Ind Pharm; 2016; 42(3):412-7. PubMed ID: 26219343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats.
    Yanyu X; Yunmei S; Zhipeng C; Qineng P
    Int J Pharm; 2006 Jan; 307(1):77-82. PubMed ID: 16300915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A (polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer)-dispersed sustained-release tablet for imperialine to simultaneously prolong the drug release and improve the oral bioavailability.
    Lin Q; Fu Y; Li J; Qu M; Deng L; Gong T; Zhang Z
    Eur J Pharm Sci; 2015 Nov; 79():44-52. PubMed ID: 26349052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seventy-two-hour release formulation of the poorly soluble drug silybin based on porous silica nanoparticles: in vitro release kinetics and in vitro/in vivo correlations in beagle dogs.
    Cao X; Deng W; Fu M; Zhu Y; Liu H; Wang L; Zeng J; Wei Y; Xu X; Yu J
    Eur J Pharm Sci; 2013 Jan; 48(1-2):64-71. PubMed ID: 23123331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative bioavailability of silibinin in healthy male volunteers.
    Kim YC; Kim EJ; Lee ED; Kim JH; Jang SW; Kim YG; Kwon JW; Kim WB; Lee MG
    Int J Clin Pharmacol Ther; 2003 Dec; 41(12):593-6. PubMed ID: 14692709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery.
    Wang Y; Zhang D; Liu Z; Liu G; Duan C; Jia L; Feng F; Zhang X; Shi Y; Zhang Q
    Nanotechnology; 2010 Apr; 21(15):155104. PubMed ID: 20332565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of the in-vitro dissolution and in-vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of semisolid dispersion using Gelucire 44/14 as a carrier.
    Hussein A; El-Menshawe S; Afouna M
    Pharmazie; 2012 Mar; 67(3):209-14. PubMed ID: 22530301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparation of silybin-phospholipid complex and its bioavailability in rats].
    Xiao YY; Song YM; Chen ZP; Ping QN
    Yao Xue Xue Bao; 2005 Jul; 40(7):611-7. PubMed ID: 16196266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of a silybin-phosphatidylcholine complex in dogs.
    Filburn CR; Kettenacker R; Griffin DW
    J Vet Pharmacol Ther; 2007 Apr; 30(2):132-8. PubMed ID: 17348898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.